Delivery Order SPE2DB22D6029-SPE2DB25FLTPV

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,601.97 firm-fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,374.60 firm-fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2023 and was awarded on December 15, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $1,399.88 firm fixed price contract is for the delivery of UBRELVY 50 MG TABLET UD 10S, a medication. The contract has a period of performance through March 14, 2024 and does not have a set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide UBRELVY 100 MG TABLET UD 10S. The contract has a firm fixed price of $3,039.33 and a completion date of June 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4564703540 UBRELVY 100 MG TABLET UD 10S, a prescription medication, with a ceiling value of $4,042.22 and a completion date of May 24, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,436.97 order is for UBRELVY 100 MG TABLET UD 16S and has a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation noted. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 50 MG TABLET UD 10S. The contract has a ceiling value of $1,411.72 and a completion date of September 17, 2024. This appears to be a delivery order placed against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,747.48, is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 2, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,367.98 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,083.58, is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTPV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.60, is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. This is a firm fixed-price contract with a performance period through January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/4/25, 9:53 AM